Recent Insider Transactions - Intellia Therapeutics (NASDAQ: NTLA)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ NTLA Intellia Therapeutics

Clark Eliana / officer: EVP, Chief Technical Officer

03/04/2025

Sell

$8.99

679

$6K

95,369

NASDAQ NTLA Intellia Therapeutics

Clark Eliana / officer: EVP, Chief Technical Officer

03/01/2025

Buy

$10.09

45,714

$461K

45,714

NASDAQ NTLA Intellia Therapeutics

LEONARD JOHN M / director, officer: President and CEO

03/01/2025

Buy

$10.09

196,000

$1.978M

196,000

NASDAQ NTLA Intellia Therapeutics

Dulac Edward J III / officer: EVP, Chief Financial Officer

03/01/2025

Buy

$10.09

67,429

$680K

67,429

NASDAQ NTLA Intellia Therapeutics

Lebwohl David / officer: EVP, Chief Medical Officer

03/01/2025

Buy

$10.09

61,714

$623K

61,714

NASDAQ NTLA Intellia Therapeutics

Schultes Birgit C / officer: EVP, Chief Scientific Officer

03/01/2025

Buy

$10.09

53,714

$542K

53,714

NASDAQ NTLA Intellia Therapeutics

BASTA JAMES / officer: EVP, General Counsel

03/04/2025

Sell

$8.99

2,572

$23K

111,925

NASDAQ NTLA Intellia Therapeutics

BASTA JAMES / officer: EVP, General Counsel

03/01/2025

Buy

$10.09

57,143

$577K

57,143